Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Size of Pelvic Hematoma Can be a Predictive Factor for Angioembolization in Hemodynamically Unstable Pelvic Trauma

NCT03519594 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT03519594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03519594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Size of Pelvic Hematoma Can be a Predictive Factor for Angioembolization in Hemodynamically Unstable Pelvic Trauma
Lead sponsor
Asan Medical Center
Phase
Observational
Overall status
Completed
Start date
January 1, 2011
Completion date
May 1, 2017
Enrollment
46 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

multiple pelvic fractures